Tag: somatostatin
Amryt gets FDA orphan drug designation for Mycapssa for carcinoid syndrome
Amryt, a commercial-stage biopharma company, has secured orphan drug designation for Mycapssa (octreotide capsules) from the US Food and Drug Administration (FDA) for the treatment ... Read More
Lexicon’s Xermelo gets FDA approval to treat carcinoid syndrome diarrhea
Lexicon Pharmaceuticals’ oral drug Xermelo (telotristat ethyl) 250mg has been approved in combination with somatostatin analog (SSA) therapy by the US Food and Drug Administration ... Read More